Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/10/24 07:30:44 on US and Canada Markets.
TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that its subsidiary, First Onsite Property Restoration (“First Onsite”), has recently acquired All Restoration Solutions, LLC (“ARS”...
Long time partners come together to expand SPS Commerce’s leadership in full-service Electronic Data Integration (EDI) with System Automation for suppliers and trading partners SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, acquired SAP B1 SPS ...
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Stifel 2024 Targeted Oncology Forum. Troy Wilson...
Primary Results from SEQUOIA-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy Two Additional Analyses from SEQUOIA-HCM Assess Effect of Aficamten on Exercise Capacity and Dosing and Safety SOUTH SAN FRANCISCO, Calif., April 10...
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today a...
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2024) - Xplore Resources Corp . (TSXV: XPLR) (" Xplore " or the " Company ") announces that it has arranged a private placement of up to 20,000,000 units (the " Units ") at $0.10 per Unit for total gross proceeds of up to $2,000,000 (the...
2024-04-10 07:17:31 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- IN8bio, Inc. (NASDAQ: INAB ) reported, after yesterday’s market close, new preclinical data from INB-300, its non-signaling gamma-delta T cell based Chimeric Antigen Receptor-T cell platform, which demo...
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated hea...
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated hea...
2024-04-10 07:15:00 ET The healthcare business never sleeps and never goes out of style. That's one of the advantages of investing in stocks in this sector. But to be successful at it, it's important to pick innovative companies that benefit from an economic moat, are leaders in their respe...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
8.04%Change Percent:
Direxion Technology Bear 3X Shares Company Name:
TECS Stock Symbol:
NYSE Market: